Total Packaging Papers shipments were 235,900 tons, 1.7 percent lower than August 2016. Bag & Sack shipments were up 5.5 percent year-to-date, while Food Wrapping shipments were down 8.5 percent over the same period. The operating rate for August 2017 was 90.3 percent, while the year-to-date rate was 88.8 percent. Inventories were 168,600 tons, down slightly since July.
http://afandpa.org/media/news/2017/09/19/american-forest-paper-association-releases-august-2017-u.s.-packaging-papers-specialty-packaging-monthly-report
Related Posts
Aptar Pharma was proud to receive an InnoPack China Award recently, in recognition of Aptar Pharma’s well-established Bag-on-Valve Technology (BOV) Platform, with a special focus on our innovative PureHale® device and Pacifica Duo Actuator. PureHale® is a portable and ready-to-use drug delivery solution designed for upper respiratory care. An industry first, this nebulizer-like device distributes a continuous fine mist to gently cleanse, moisturize and soothe the upper respiratory tract. Aptar Pharma’s Pacifica Duo is a twistable actuator that fulfills two needs in one applicator – spray for gentle application and jet for rinsing -providing flexibility to users.
First Quarter Highlights and other notable items: *Net sales of $4.6 billion; Corrugated Packaging segment sales increased 3.5% compared to the prior year quarter *Global Paper containerboard shipments increased 21.9% compared to the prior year quarter *Net loss of $22 million; net loss included $66 million of restructuring and other costs *Achieved over $200 million in cost savings; expect to significantly exceed previously announced fiscal 2024 target of $300 to $400 million
Q3 2022 Highlights *Sales of $1,174 million (compared with $1,119 million in Q2 2022 and $1,030 million in Q3 2021) **As reported (including specific items) *Operating income of $25 million (compared with $32 million in Q2 2022 and $73 million in Q3 2021) *Operating income before depreciation and amortization (OIBD) of $92 million (compared with $95 million in Q2 2022 and $136 million in Q3 2021)